ADAPT FDA Approval NDA 208411

NDA 208411

ADAPT

FDA Drug Application

Application #208411

Documents

Letter2015-11-19
Label2015-11-18
Review2016-07-28
Label2017-01-24
Summary Review2017-01-27
Letter2017-01-27
Pediatric DD Summary Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric CDTL Review1900-01-01
Label2019-10-01
Letter2020-09-16
Label2020-09-18

Application Sponsors

NDA 208411ADAPT

Marketing Status

Prescription001
Discontinued002

Application Products

001SPRAY, METERED;NASAL4MG/SPRAY1NARCANNALOXONE HYDROCHLORIDE
002SPRAY, METERED;NASAL2MG/SPRAY1NARCANNALOXONE HYDROCHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2015-11-18PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2019-09-23N/A
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2020-08-06N/A

Submissions Property Types

ORIG1Null6
SUPPL2Null6

TE Codes

001PrescriptionAB

CDER Filings

EMERGENT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208411
            [companyName] => EMERGENT
            [docInserts] => ["",""]
            [products] => [{"drugName":"NARCAN","activeIngredients":"NALOXONE HYDROCHLORIDE","strength":"4MG\/SPRAY","dosageForm":"SPRAY, METERED;NASAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"NARCAN","activeIngredients":"NALOXONE HYDROCHLORIDE","strength":"2MG\/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"SPRAY, METERED;NASAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"08\/06\/2020","submission":"SUPPL-4","supplementCategories":"Manufacturing (CMC)-Expiration Date","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/208411Orig1s004lbl.pdf\"}]","notes":""},{"actionDate":"09\/23\/2019","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/208411Orig1s002lbl.pdf\"}]","notes":""},{"actionDate":"01\/24\/2017","submission":"SUPPL-1","supplementCategories":"Efficacy-Manufacturing Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/208411s001lbl.pdf\"}]","notes":""},{"actionDate":"11\/18\/2015","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/208411lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"11\/18\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 3 - New Dosage Form","reviewPriority":"PRIORITY","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/208411lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/208411Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2015\\\/208411Orig1s000TOC.cfm\"}]","notes":">"}]
            [supplements] => [{"actionDate":"08\/06\/2020","submission":"SUPPL-4","supplementCategories":"Manufacturing (CMC)-Expiration Date","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/208411Orig1s004lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/208411Orig1s004ltr.pdf\"}]","notes":">"},{"actionDate":"09\/23\/2019","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/208411Orig1s002lbl.pdf\"}]","notes":">"},{"actionDate":"01\/24\/2017","submission":"SUPPL-1","supplementCategories":"Efficacy-Manufacturing Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/208411s001lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/208411Orig1s001ltr.pdf\"},{\"name\":\"Summary Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/summary_review\\\/2017\\\/208411s001SumR.pdf\"}]","notes":">"}]
            [actionDate] => 2020-08-06
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.